IRIS
CUBELLIS, MARIA VITTORIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.161
NA - Nord America 3.835
EU - Europa 2.455
SA - Sud America 463
Continente sconosciuto - Info sul continente non disponibili 193
AF - Africa 108
OC - Oceania 6
Totale 11.221
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.684
SG - Singapore 1.977
RU - Federazione Russa 1.232
VN - Vietnam 767
CN - Cina 687
BR - Brasile 355
HK - Hong Kong 337
IT - Italia 313
FR - Francia 155
DE - Germania 150
FI - Finlandia 116
UA - Ucraina 97
GB - Regno Unito 80
SE - Svezia 80
IE - Irlanda 77
CA - Canada 76
BD - Bangladesh 62
JP - Giappone 60
IN - India 58
NL - Olanda 49
AR - Argentina 47
MX - Messico 38
CI - Costa d'Avorio 37
KR - Corea 32
PL - Polonia 29
IQ - Iraq 27
ZA - Sudafrica 23
AT - Austria 22
PH - Filippine 22
TH - Thailandia 22
ID - Indonesia 19
CO - Colombia 16
TR - Turchia 16
ES - Italia 15
PK - Pakistan 15
PY - Paraguay 13
EC - Ecuador 12
KE - Kenya 9
VE - Venezuela 9
JM - Giamaica 8
UZ - Uzbekistan 8
CL - Cile 7
LT - Lituania 7
MA - Marocco 7
DZ - Algeria 6
EG - Egitto 6
TW - Taiwan 6
AU - Australia 5
GT - Guatemala 5
IL - Israele 5
TT - Trinidad e Tobago 5
HU - Ungheria 4
NP - Nepal 4
PS - Palestinian Territory 4
AE - Emirati Arabi Uniti 3
BE - Belgio 3
CH - Svizzera 3
DK - Danimarca 3
JO - Giordania 3
KZ - Kazakistan 3
LB - Libano 3
LU - Lussemburgo 3
OM - Oman 3
PA - Panama 3
PR - Porto Rico 3
RO - Romania 3
SA - Arabia Saudita 3
TN - Tunisia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AZ - Azerbaigian 2
BN - Brunei Darussalam 2
BZ - Belize 2
CG - Congo 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
HN - Honduras 2
MN - Mongolia 2
MY - Malesia 2
PE - Perù 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DM - Dominica 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GD - Grenada 1
GY - Guiana 1
Totale 11.010
Salva come PNG Salva come JPEG
Città #
Singapore 977
San Jose 512
Hong Kong 323
Chandler 317
Moscow 310
Santa Clara 295
Ashburn 245
Ho Chi Minh City 195
Beijing 183
Hanoi 163
Lauterbourg 101
Los Angeles 101
The Dalles 97
Hefei 96
Jacksonville 92
Millbury 84
Princeton 83
Boston 78
New York 75
Nanjing 63
Naples 53
Tokyo 50
Munich 45
Napoli 44
Redondo Beach 44
Da Nang 43
Buffalo 42
Wilmington 36
Council Bluffs 35
Dallas 34
Des Moines 34
Ottawa 34
Orem 33
Amsterdam 32
Haiphong 31
São Paulo 29
Chicago 28
Warsaw 25
Brooklyn 24
Atlanta 23
Mexico City 22
Nanchang 22
Nuremberg 21
Rome 21
Denver 20
Frankfurt am Main 20
Lawrence 18
San Francisco 18
Seoul 18
Hebei 17
Lappeenranta 17
Montreal 17
Seattle 17
Chennai 16
Milan 16
Stockholm 16
Woodbridge 15
Ann Arbor 14
Biên Hòa 14
Poplar 14
Shenyang 14
St Petersburg 14
Baghdad 13
Falls Church 13
London 13
Norwalk 13
Phoenix 13
Dong Ket 12
Hải Dương 12
Jiaxing 12
Manchester 12
Helsinki 11
Vienna 11
Belo Horizonte 10
Boardman 10
Johannesburg 10
Kronberg 10
Mumbai 10
Paris 10
Bangkok 9
Bình Phước 9
Falkenstein 9
Nha Trang 9
Ninh Bình 9
Toronto 9
Dublin 8
Guangzhou 8
Houston 8
New Delhi 8
Tashkent 8
Tianjin 8
Ankara 7
Berlin 7
Brasília 7
Casavatore 7
Changsha 7
Fairfield 7
Rio de Janeiro 7
Điện Bàn 7
Asunción 6
Totale 5.849
Salva come PNG Salva come JPEG
Nome #
Looking for protein stabilizing drugs with thermal shift assay. 263
PHYSICO-CHEMICAL CHARACTERZATION OF GEODIN: A NEW B, G- CRYSTALLINE- TYPE PROTEIN SPONGE 171
Ribonucleases and angiogenins from fish. 163
A mutant of phosphomannomutase1 retains full enzymatic activity, but is not activated by IMP: Possible implications for the disease PMM2-CDG 150
Pharmacological chaperones: A therapeutic approach for diseases caused by destabilizing missense mutations 150
The Analysis of Variants in the General Population Reveals That PMM2 Is Extremely Tolerant to Missense Mutations and That Diagnosis of PMM2-CDG Can Benefit from the Identification of Modifiers 143
Why does SARS-CoV-2 hit in different ways? Host genetic factors can influence the acquisition or the course of COVID-19 138
Protective role of a tmprss2 variant on severe covid-19 outcome in young males and elderly women 138
Heterodimerization of Two Pathological Mutants Enhances the Activity of Human Phosphomannomutase2 136
Drug Repositioning for Fabry Disease: Acetylsalicylic Acid Potentiates the Stabilization of Lysosomal Alpha-Galactosidase by Pharmacological Chaperones 135
Bioinformatics tools for marine biotechnology: A practical tutorial with a metagenomic approach 132
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 129
A maternal-effect Padi6 variant causes nuclear and cytoplasmic abnormalities in oocytes, as well as failure of epigenetic reprogramming and zygotic genome activation in embryos 127
D2A-Ala peptide derived from the urokinase receptor exerts anti-tumoural effects in vitro and in vivo 127
β-Glucose-1,6-Bisphosphate Stabilizes Pathological Phophomannomutase2 Mutants In Vitro and Represents a Lead Compound to Develop Pharmacological Chaperones for the Most Common Disorder of Glycosylation, PMM2-CDG 123
Novel genetic variants of KHDC3L and other members of the subcortical maternal complex associated with Beckwith–Wiedemann syndrome or Pseudohypoparathyroidism 1B and multi-locus imprinting disturbances 120
Curcumin Has Beneficial Effects on Lysosomal Alpha-Galactosidase: Potential Implications for the Cure of Fabry Disease 119
Relaxation of Insulin-like growth factor-2 imprinting and discordant methylation at KvDMR1 in two first-cousins affected by Beckwith-Wiedemann and Klippel-Trenaunay-Weber syndromes 119
Indole-3-glycerol-phosphate Synthase From Sulfolobus-solfataricus As A Model For Studying Thermostable Tim-barrel Enzymes 119
Proteostasis regulators modulate proteasomal activity and gene expression to attenuate multiple phenotypes in Fabry disease 119
Expression of a hyperthermophilic aspartate aminotransferase in Escherichia coli 118
Identification of an Allosteric Binding Site on Human Lysosomal Alpha-Galactosidase Opens the Way to New Pharmacological Chaperones for Fabry Disease 118
In vitro enzyme measurement to test pharmacological chaperone responsiveness in fabry and pompe disease 117
Data on the inhibition of cell proliferation and invasion by the D2A-Ala peptide derived from the urokinase receptor 117
Inherited and Sporadic Epimutations at the IGF2-H19 locus in Beckwith-Wiedemann syndrome and Wilms' tumor. 116
The Large Phenotypic Spectrum of Fabry Disease Requires Graduated Diagnosis and Personalized Therapy: A Meta-Analysis Can Help to Differentiate Missense Mutations 116
Stability of a thermophilic TIM-barrel enzyme: indolglycerol-phosphate synthase from the thermophilic archaeon Sulfolobus solfataricus. 115
Loss-of-function maternal-effect mutations of PADI6 are associated with familial and sporadic Beckwith-Wiedemann syndrome with multi-locus imprinting disturbance 115
The Functioning of Sulfolobus-solfataricus Aspartate-aminotransferase 115
Challenging popular tools for the annotation of genetic variations with a real case, pathogenic mutations of lysosomal alpha-galactosidase 114
Limited proteolysis as a probe of conformational changes in aspartate aminotransferase from Sulfolobus solfataricus 113
Molecular characterization of G6PD deficiency in Southern Italy: heterogeneity, correlation genotype-phenotype and description of a new variant (G6PD Neapolis). 112
Stability of aspartate aminotransferase from Sulfolobus solfataricus. 112
Drug repositioning can accelerate discovery of pharmacological chaperones. 111
IN SILICO DOCKING OF UROKINASE PLASMINOGEN ACTIVATOR AND INTEGRINS 109
Aspartate-aminotransferase From Sulfolobus-solfataricus - A Hyperthermophilic Enzyme 109
An intron-less betagamma-crystallin-type gene from the sponge Geodia cydonium. 107
Tryptophan Biosynthesis Genes TrpEGC In the Thermoacidophilic Archaebacterium Sulfolobus-solfataricus 107
D2A sequence of the urokinase receptor induces cell growth through αvβ3 integrin and EGFR 107
PEGYLATION, THE ULTIMATE STRATEGY TO IMPROVE THE IN VIVO EFFICIENCY OF BIOACTIVE COMPOUNDS 107
Drug Repurposing and Lysosomal Storage Disorders: A Trick to Treat 106
Mechanistic Insight into the Mode of Action of Acid β-Glucosidase Enhancer Ambroxol 105
Identification of trombospondin-1 as a novel amelogenin interactor by functional proteomics 104
Biallelic variant in cyclin B3 is associated with failure of maternal meiosis II and recurrent digynic triploidy 104
Properties of polyproline II, a secondary structure element implicated in protein-protein interaction 103
An extremely thermostable aromatic aminotransferase from the hyperthermophilic archaeon Pyrococcus furiosus. 102
A Key Molecule Dictating and Regulating Surface Plasmin Formation : The Receptor for Urokinase Plasminogen ActivatorSerine Proteases and Their Serpin Inhibitors in the Nervous System 102
Passenger mutations as a target for the personalized therapy of cancer 101
Inherited and Sporadic Epimutations at the IGF2-H19 Locus in Beckwith-Wiedemann Syndrome and Wilms’ Tumor. In: Endocrine Involvement in Developmental Syndromes. 99
Assessment of gene variant amenability for pharmacological chaperone therapy with 1-deoxygalactonojirimycin in fabry disease 99
ReBaTSA: A simplified CeTSA protocol for studying recombinant mutant proteins in bacterial extracts 98
Stability of aspartate aminotransferase from Sulfolobus solfataricus 98
An EcoRI polymorphism for the PLAUR gene 97
Use of fast protein liquid chromatography (FPLC) for the purification of synthetic oligonucleotides 96
Comparative studies on thermophilicity and thermostability of aspartate aminotransferases. 95
Environment specific substitution tables for thermophilic proteins 94
Different Mechanisms Cause Imprinting defects at the IGF2/H19 locus in Beckwith-Wiedemann Syndrome and Wilms’ Tumour. 93
Secondary structure assignment that more accurately reflects physical and evolutionary characteristics. 92
The active site of Sulfolobus solfataricus aspartate aminotransferase 91
Exploring ligand interactions with human phosphomannomutases using recombinant bacterial thermal shift assay and biochemical validation 89
Conformational response to ligand binding in phosphomannomutase2: insights into inborn glycosylation disorder. 89
Enzymes from extreme thermophilic bacteria as special catalysts: studies on a beta -galactosidase from Sulfolobus solfataricus 88
Beneficial effects of Glc-1,6-P2 modulation on mutant phosphomannomutase-2 87
Use of fast protein liquid chromatography for the purification of synthetic oligonucleotides 86
An open reading frame in intron seven of the sea urchin DNA-methyltransferase gene codes for a functional AP1 endonuclease. 85
An intron-less βγ-crystallin-type gene from the sponge Geodia cydonium 85
Identification of a novel mutation in the myosin VIIA motor domain in a family with autosomal dominant hearing loss (DFNA11). 83
Autocrine saturation of pro-urokinase receptors on human A431 cells. 83
The KCNQ1OT1 Imprinting Control Region and non-coding RNA: new properties derived from the study of Beckwith-Wiedemann syndrome and Silver-Russell syndrome cases. 82
Fabry_CEP: a tool to identify Fabry mutations responsive to pharmacological chaperones. 82
(Epi)genotype-phenotype correlations in Beckwith-Wiedemann syndrome. 82
Biochemical phenotype of a common disease-causing mutation and a possible therapeutic approach for the phosphomannomutase 2-associated disorder of glycosylation 81
The pharmacological chaperone 1-deoxynojirimycin increases the activity and lysosomal trafficking of multiple mutant forms of acid alpha-glucosidase 80
Relaxation of Insulin-like Growth Factor 2 Imprinting and Discordant Methylation at KvDMR1 in Two First Cousins Affected by Beckwith-Wiedemann and Klippel-Trenaunay-Weber Syndromes 80
Binding of single-chain prourokinase to the urokinase receptor of human U937 cells. 80
Frequent pathological human mutations: a survey. 80
Antitumor Action of Seminal Ribonuclease, Its Dimeric Structure, and Its Resistance to the Cytosolic Ribonuclease Inhibitor† 79
An ORF in the intron seven of the sea urchin DNA-methyltransferase gene codes for a functional AP1 endonuclease 77
Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. 77
The receptor for urokinase-plasminogen activator 77
Polyproline II in protein interactions 76
Gain of function in CDKN1C 75
A thermodynamic assay to test pharmacological chaperones for Fabry disease. 72
In Silico Analysis of Phosphomannomutase-2 Dimer Interface Stability and Heterodimerization with Phosphomannomutase-1 69
Bioinformatics-Driven Multi-Factorial Insight into α-Galactosidase Mutations 69
The urokinase receptor and regulation of cell surface plasminogen activation 69
Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor. 68
Fetal growth patterns in Beckwith-Wiedemann syndrome 68
Use of Fast Protein Liquid-chromatography For the Purification of Synthetic Oligonucleotides 67
Characterization of aromatic aminotransferases from the hyperthermophilic archaeon Thermococcus litoralis. 66
Silver-Russell syndrome- and Beckwith-Wiedemann syndrome- phenotypes associated with 11p duplication in a single family. 66
Isolation and sequencing of a new β-galactosidase-encoding archaebacterial gene 66
Cloning, Sequencing and Expression of A New Beta-galactosidase From the Extreme Thermophilic Sulfolobus-solfataricus 66
Identification of a novel mutation in the myosin VIIA motor domain in a family with autosomal dominant hearing loss (DFNA11). 65
Hypomethylation at multiple maternally methylated imprinted regions including PLAGL1 and GNAS loci in Beckwith-Wiedemann syndrome. 64
Prediction of the responsiveness to pharmacological chaperones: lysosomal human alpha-galactosidase, a case of study 64
Cloning and sequencing of the gene coding for aspartate aminotransferase from the thermoacidophilic archaebacterium Sulfolobus solfataricus 64
Preparation and characterization of geodin. A betagamma-crystallin-type protein from a sponge. 63
The molecular function and clinical phenotype of partial deletions of the IGF2/H19 imprinting control region depends on the spatial arrangement of the remaining CTCF binding sites 63
Congenital disorders of glycosylation: narration of a story through its patents 62
Totale 10.029
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.458
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.458
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022487 0 0 12 2 5 9 8 16 78 35 80 242
2022/2023677 108 97 18 45 84 81 13 60 108 23 31 9
2023/2024392 27 77 36 15 22 12 3 48 10 10 96 36
2024/20253.031 200 208 12 32 125 192 343 163 208 306 954 288
2025/20265.430 573 388 472 541 961 294 505 359 741 367 125 104
2026/2027298 123 175 0 0 0 0 0 0 0 0 0 0
Totale 11.221